325 related articles for article (PubMed ID: 17051425)
1. Lycopene and other carotenoids inhibit estrogenic activity of 17beta-estradiol and genistein in cancer cells.
Hirsch K; Atzmon A; Danilenko M; Levy J; Sharoni Y
Breast Cancer Res Treat; 2007 Aug; 104(2):221-30. PubMed ID: 17051425
[TBL] [Abstract][Full Text] [Related]
2. Genistein in the presence of 17beta-estradiol inhibits proliferation of ERbeta breast cancer cells.
Rajah TT; Du N; Drews N; Cohn R
Pharmacology; 2009; 84(2):68-73. PubMed ID: 19556829
[TBL] [Abstract][Full Text] [Related]
3. Phytoestrogens modulate binding response of estrogen receptors alpha and beta to the estrogen response element.
Kostelac D; Rechkemmer G; Briviba K
J Agric Food Chem; 2003 Dec; 51(26):7632-5. PubMed ID: 14664520
[TBL] [Abstract][Full Text] [Related]
4. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
Menendez JA; Oza BP; Colomer R; Lupu R
Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
[TBL] [Abstract][Full Text] [Related]
5. Phytoestrogens activate estrogen receptor beta1 and estrogenic responses in human breast and bone cancer cell lines.
Chrzan BG; Bradford PG
Mol Nutr Food Res; 2007 Feb; 51(2):171-7. PubMed ID: 17266178
[TBL] [Abstract][Full Text] [Related]
6. Anti-estrogenic effect of unliganded progesterone receptor is estrogen-selective in breast cancer cells MCF-7.
Zheng ZY; Lin VC
Cancer Lett; 2008 Sep; 268(2):202-11. PubMed ID: 18477500
[TBL] [Abstract][Full Text] [Related]
7. Stimulatory effect of genistein and apigenin on the growth of breast cancer cells correlates with their ability to activate ER alpha.
Seo HS; DeNardo DG; Jacquot Y; Laïos I; Vidal DS; Zambrana CR; Leclercq G; Brown PH
Breast Cancer Res Treat; 2006 Sep; 99(2):121-34. PubMed ID: 16541309
[TBL] [Abstract][Full Text] [Related]
8. Effects of acyclo-retinoic acid and lycopene on activation of the retinoic acid receptor and proliferation of mammary cancer cells.
Ben-Dor A; Nahum A; Danilenko M; Giat Y; Stahl W; Martin HD; Emmerich T; Noy N; Levy J; Sharoni Y
Arch Biochem Biophys; 2001 Jul; 391(2):295-302. PubMed ID: 11437362
[TBL] [Abstract][Full Text] [Related]
9. Genistein and daidzein induce cell proliferation and their metabolites cause oxidative DNA damage in relation to isoflavone-induced cancer of estrogen-sensitive organs.
Murata M; Midorikawa K; Koh M; Umezawa K; Kawanishi S
Biochemistry; 2004 Mar; 43(9):2569-77. PubMed ID: 14992594
[TBL] [Abstract][Full Text] [Related]
10. Phytoestrogens and breast cancer: a complex story.
Helferich WG; Andrade JE; Hoagland MS
Inflammopharmacology; 2008 Oct; 16(5):219-26. PubMed ID: 18815740
[TBL] [Abstract][Full Text] [Related]
11. Effects of diverse dietary phytoestrogens on cell growth, cell cycle and apoptosis in estrogen-receptor-positive breast cancer cells.
Sakamoto T; Horiguchi H; Oguma E; Kayama F
J Nutr Biochem; 2010 Sep; 21(9):856-64. PubMed ID: 19800779
[TBL] [Abstract][Full Text] [Related]
12. Modulation of estrogen receptor-beta isoforms by phytoestrogens in breast cancer cells.
Cappelletti V; Miodini P; Di Fronzo G; Daidone MG
Int J Oncol; 2006 May; 28(5):1185-91. PubMed ID: 16596234
[TBL] [Abstract][Full Text] [Related]
13. Polyphenols, isothiocyanates, and carotenoid derivatives enhance estrogenic activity in bone cells but inhibit it in breast cancer cells.
Veprik A; Khanin M; Linnewiel-Hermoni K; Danilenko M; Levy J; Sharoni Y
Am J Physiol Endocrinol Metab; 2012 Oct; 303(7):E815-24. PubMed ID: 21878663
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of oestrogenic properties of eight phytoestrogens in MCF7 human breast cancer cells.
Matsumura A; Ghosh A; Pope GS; Darbre PD
J Steroid Biochem Mol Biol; 2005 Apr; 94(5):431-43. PubMed ID: 15876408
[TBL] [Abstract][Full Text] [Related]
15. Global gene expression profiles induced by phytoestrogens in human breast cancer cells.
Dip R; Lenz S; Antignac JP; Le Bizec B; Gmuender H; Naegeli H
Endocr Relat Cancer; 2008 Mar; 15(1):161-73. PubMed ID: 18310284
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, structure, and estrogenic activity of 4-amino-3-(2-methylbenzyl)coumarins on human breast carcinoma cells.
Jacquot Y; Laïos I; Cleeren A; Nonclercq D; Bermont L; Refouvelet B; Boubekeur K; Xicluna A; Leclercq G; Laurent G
Bioorg Med Chem; 2007 Mar; 15(6):2269-82. PubMed ID: 17275315
[TBL] [Abstract][Full Text] [Related]
17. Physiologic levels of 2-methoxyestradiol interfere with nongenomic signaling of 17beta-estradiol in human breast cancer cells.
Vijayanathan V; Venkiteswaran S; Nair SK; Verma A; Thomas TJ; Zhu BT; Thomas T
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2038-48. PubMed ID: 16609013
[TBL] [Abstract][Full Text] [Related]
18. Combinatory effects of phytoestrogens and 17beta-estradiol on proliferation and apoptosis in MCF-7 breast cancer cells.
Schmidt S; Michna H; Diel P
J Steroid Biochem Mol Biol; 2005 Apr; 94(5):445-9. PubMed ID: 15876409
[TBL] [Abstract][Full Text] [Related]
19. Effects of genistein on the mammary gland proliferation of adult ovariectomised Wistar rats.
Hertrampf T; Schmidt S; Seibel J; Laudenbach-Leschowsky U; Degen GH; Diel P
Planta Med; 2006 Mar; 72(4):304-10. PubMed ID: 16557470
[TBL] [Abstract][Full Text] [Related]
20. Anti-estrogenic mechanism of unliganded progesterone receptor isoform B in breast cancer cells.
Zheng ZY; Zheng SM; Bay BH; Aw SE; C-L Lin V
Breast Cancer Res Treat; 2008 Jul; 110(1):111-25. PubMed ID: 17687644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
